FDA Quality Management Maturity Pilot Programs

November 18, 2020

Parexel’s Paul Bridges, SVP Regulatory & Access and Lynne Ensor, Head of Global Compliance outline the benefits for drug manufacturers in participating in two new FDA pilot programs. These include API’s for Foreign Facilities and Finished Dosage Forms for Domestic (US) Drug Product Manufacturers.

Previous Video
Accelerated Pathways – Alberto Grignolo
Accelerated Pathways – Alberto Grignolo

Next Video
Video for Social Media
Video for Social Media